(Total Views: 475)
Posted On: 11/12/2022 4:09:17 AM
Post# of 36541
Bad business day for me as two trucks broke down so I crashed on my couch at 8 pm lol. Let’s look at this-
Claim:
“The Debtor Does Not Own 64,153,151 Shares of NGIO Common Stock
11. Prior to October 22, 2020, the Debtor owned 64,153,151 shares of NGIO common stock.
12. On October 22, 2020, the Debtor entered into separate agreements titled “Restricted Stock Award Agreement, Settlement Agreement and Release” (the “Compensation Settlement Agreements”) with certain former key employees of the Debtor, including the Objecting Parties, in order to settle all past due compensation owed from the Debtor to such employees.
13. In particular, the Debtor entered into the Compensation Settlement Agreements with each of Terry Thompson, Richard Purcell, Dr. Jason Terrell and Anthony Crisci. Copies of those Compensation Settlement Agreements are attached collectively as Exhibit “C”.
14. Pursuant to the Compensation Settlement Agreements, each of the Objecting Parties were granted a combination of cash and common stock in each of the Debtor and NGIO to resolve the total compensation otherwise due. Exhibit A to each of the Compensation Settlement Agreements sets for the schedule of cash and stock to be provided to the respective Objecting Party by the Debtor.
15. As a result of the Compensation Settlement Agreements, out of the 64,153,151 shares of NGIO common stock that were owned by the Debtor, the following shares of NGIO common stock were granted to the Objecting Parties:
Terry Thompson: 10,862,504 shares
Richard Purcell: 5,604,259 shares
Anthony Crisci: 7,869,104 shares
Jason Terrell, MD: 3,351,791 shares
16. The Debtor’s board of directors approved and ratified the Compensation Settlement Agreements on February 17, 2021, which became effective on March 24, 2021.
17. As such, the Debtor does not own all of the shares in NGIO it purports to sell.”
_______
These four Headless Horsemen, (in my opinion) should check the last official SEC filing by NuGenerex ImmunoOncology.
Because April comes after March when in the same year. If this group became such majority owners of NGIO or NGUX, they as officers or BOD members should’ve approved or at least been aware of the later filing. Here’s a snippet:
“On February 2, 2021, the Company issued 100,000 shares of the Company's Series A Super Voting Preferred Stock (the “Super Voting Preferred Stock"
to Generex in exchange for 300,000,000 shares of the Company's common stock, which were immediately cancelled after the exchange. As of April 30, 2021, The Company now has 100,300,000 shares of common stock outstanding of which Generex owns 64,153,151 shares. The Super Voting Preferred Stock votes with the common stock and is entitled to 3,000 votes per share. The 300,000,000 shares cancelled by Generex will be available for future issuance.”
It officially and therefore legally states on a later SEC filing that Generex owns 64.163,151 shares as the Trustee property noted. Facts are facts. SEC Enforcement should investigate those later, innmy opinion, trying to harm shareholders. Especially, of the later NuGenerex Immino filing was also signed by one, In my opinion trying to change previous fscts at a later time, signed his signature saying in April that Generex owned exactly what the Trustee states in the bankruptcy filings.
The Four Headless Horsemen, stated in my opinion, should explain these FACTS, plus why they possibly deserved taking near half of the value owned by us as shareholders, while allowing the company to completely fail, rather than trying to actually invest and find investors so they could be the “Stalking Horse”.
SEC Enforcement must investigate their claims. GNBT/NGIO deserve truth and not to be taken advantage of in this and other ways. Im my humble opinion.
Claim:
“The Debtor Does Not Own 64,153,151 Shares of NGIO Common Stock
11. Prior to October 22, 2020, the Debtor owned 64,153,151 shares of NGIO common stock.
12. On October 22, 2020, the Debtor entered into separate agreements titled “Restricted Stock Award Agreement, Settlement Agreement and Release” (the “Compensation Settlement Agreements”) with certain former key employees of the Debtor, including the Objecting Parties, in order to settle all past due compensation owed from the Debtor to such employees.
13. In particular, the Debtor entered into the Compensation Settlement Agreements with each of Terry Thompson, Richard Purcell, Dr. Jason Terrell and Anthony Crisci. Copies of those Compensation Settlement Agreements are attached collectively as Exhibit “C”.
14. Pursuant to the Compensation Settlement Agreements, each of the Objecting Parties were granted a combination of cash and common stock in each of the Debtor and NGIO to resolve the total compensation otherwise due. Exhibit A to each of the Compensation Settlement Agreements sets for the schedule of cash and stock to be provided to the respective Objecting Party by the Debtor.
15. As a result of the Compensation Settlement Agreements, out of the 64,153,151 shares of NGIO common stock that were owned by the Debtor, the following shares of NGIO common stock were granted to the Objecting Parties:
Terry Thompson: 10,862,504 shares
Richard Purcell: 5,604,259 shares
Anthony Crisci: 7,869,104 shares
Jason Terrell, MD: 3,351,791 shares
16. The Debtor’s board of directors approved and ratified the Compensation Settlement Agreements on February 17, 2021, which became effective on March 24, 2021.
17. As such, the Debtor does not own all of the shares in NGIO it purports to sell.”
_______
These four Headless Horsemen, (in my opinion) should check the last official SEC filing by NuGenerex ImmunoOncology.
Because April comes after March when in the same year. If this group became such majority owners of NGIO or NGUX, they as officers or BOD members should’ve approved or at least been aware of the later filing. Here’s a snippet:
“On February 2, 2021, the Company issued 100,000 shares of the Company's Series A Super Voting Preferred Stock (the “Super Voting Preferred Stock"
to Generex in exchange for 300,000,000 shares of the Company's common stock, which were immediately cancelled after the exchange. As of April 30, 2021, The Company now has 100,300,000 shares of common stock outstanding of which Generex owns 64,153,151 shares. The Super Voting Preferred Stock votes with the common stock and is entitled to 3,000 votes per share. The 300,000,000 shares cancelled by Generex will be available for future issuance.” It officially and therefore legally states on a later SEC filing that Generex owns 64.163,151 shares as the Trustee property noted. Facts are facts. SEC Enforcement should investigate those later, innmy opinion, trying to harm shareholders. Especially, of the later NuGenerex Immino filing was also signed by one, In my opinion trying to change previous fscts at a later time, signed his signature saying in April that Generex owned exactly what the Trustee states in the bankruptcy filings.
The Four Headless Horsemen, stated in my opinion, should explain these FACTS, plus why they possibly deserved taking near half of the value owned by us as shareholders, while allowing the company to completely fail, rather than trying to actually invest and find investors so they could be the “Stalking Horse”.
SEC Enforcement must investigate their claims. GNBT/NGIO deserve truth and not to be taken advantage of in this and other ways. Im my humble opinion.
(6)
(0)Scroll down for more posts ▼
